These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6471444)

  • 1. [Enhanced neutrophilic functions in mucocutaneous lymph node syndrome (MCLS). With special reference to the possible role of increased active oxygen generation in the pathogenesis of coronary thromboarteritis].
    Niwa Y; Yanagida I; Somiya K
    Rinsho Ketsueki; 1984 May; 25(5):619-26. PubMed ID: 6471444
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced neutrophilic functions in mucocutaneous lymph node syndrome, with special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis.
    Niwa Y; Sohmiya K
    J Pediatr; 1984 Jan; 104(1):56-60. PubMed ID: 6690675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing coronary artery aneurysms in patients with mucocutaneous lymph node syndrome (Kawasaki's disease).
    Arensman FW; Sharp CG; Covitz W; Strong WB
    J Med Assoc Ga; 1984 Jul; 73(7):491-5. PubMed ID: 6747494
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the platelet mucocutaneous lymph node syndrome (MCLS)--platelet function--].
    Mukaiyama H
    Rinsho Ketsueki; 1982 Apr; 23(4):449-58. PubMed ID: 6215508
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional right ventricular wall motion in patients with obstruction of the right coronary artery due to the mucocutaneous lymph node syndrome.
    Watanabe K; Echigo S; Kamiya T; Sugiyama H; Suzuki A; Kozuka T
    J Cardiogr; 1984 Dec; 14(4):697-706. PubMed ID: 6543870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kawasaki disease (mucocutaneous lymph node syndrome). Report of 7 cases and brief review].
    Sakane PT; de Mendonça JS; Mazzucato G; Pannuti CS; Amato Neto V
    Rev Paul Med; 1983; 101(2):62-7. PubMed ID: 6622895
    [No Abstract]   [Full Text] [Related]  

  • 7. Two-dimensional echocardiographic visualization of the peripheral right coronary artery in patients with mucocutaneous lymph node syndrome.
    Saito A; Ueda K; Nakano H
    J Cardiogr; 1982 Jun; 12(2):401-13. PubMed ID: 7175225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of coronary aneurysm in Kawasaki disease--correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils.
    Nakano M
    Prog Clin Biol Res; 1987; 250():535-7. PubMed ID: 3423065
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sequelae of Kawasaki disease].
    Takase B; Ohtomi S
    Ryoikibetsu Shokogun Shirizu; 1996; (15):406-10. PubMed ID: 9048054
    [No Abstract]   [Full Text] [Related]  

  • 10. Kawasaki disease. Mucocutaneous lymph node syndrome or MCLS.
    Kawasaki T
    Acta Pathol Jpn; 1982; 32 Suppl 1():63-72. PubMed ID: 7187577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of coronary aneurysm after Kawasaki's disease (mucocutaneous lymphnode syndrome, MCLS) (author's transl)].
    Yamamoto N; Morikawa T; Okubo T; Nakada S; Osawa M; Suzuki A
    Kyobu Geka; 1980 Aug; 33(8):598-602. PubMed ID: 6967996
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on peripheral blood mononuclear cell subpopulations in patients with Kawasaki disease by fluorescence activated cell sorter using two-colour immunofluorescence staining].
    Jujho K
    Arerugi; 1985 Dec; 34(12):1072-80. PubMed ID: 2420314
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma fibronectin concentrations in mucocutaneous lymph node syndrome.
    Shimizu S; Kuratsuji T; Ojima T; Takahashi E
    Arch Dis Child; 1986 Jan; 61(1):72-4. PubMed ID: 3954421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological study of Kawasaki disease (MCLS): with special reference to sequelae.
    Tanaka N
    Jpn J Med Sci Biol; 1979 Aug; 32(4):245-6. PubMed ID: 529604
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular involvement in Kawasaki disease.
    Baba K; Kitani K; Mitomori H; Mitsudo K; Tanaka M
    Prog Clin Biol Res; 1987; 250():515-6. PubMed ID: 3423058
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary artery involvement in Kawasaki disease--diagnosis and treatment.
    Anand A; Anand A
    West J Med; 1995 Oct; 163(4):393. PubMed ID: 7483610
    [No Abstract]   [Full Text] [Related]  

  • 17. Kawasaki disease: who is at risk?
    Newburger JW
    J Pediatr; 2000 Aug; 137(2):149-52. PubMed ID: 10931403
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current viewpoints in the pathogenesis of Kawasaki disease].
    Bollen CW; Rijkers GT; Zegers BJ; de Graeff-Meeder ER
    Ned Tijdschr Geneeskd; 1995 Mar; 139(11):549-54. PubMed ID: 7700390
    [No Abstract]   [Full Text] [Related]  

  • 19. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent.
    Yamada K; Fukumoto T; Shinkai A; Shirahata A; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):791-802. PubMed ID: 716791
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased circulating granulocyte colony-stimulating factor in acute Kawasaki disease.
    Inoue Y; Kato M; Kobayashi T; Shinohara M; Sone K; Morikawa A
    Pediatr Int; 1999 Jun; 41(3):330-3. PubMed ID: 10365591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.